AkkoLens has developed a ground-breaking innovation with the potential to revolutionise the entire intraocular lens (IOL) market. Perhaps even more profoundly than refractive surgery did three decades ago. AkkoLens’ IOL draws inspiration from the lens system pioneered by the American physicist and Nobel Prize Winner, Luis Alvarez. This innovation has been further refined and patented by AkkoLens.
This extraordinary technological product is known as the “Lumina lens” and it has the remarkable ability to restore vision without the need for glasses. It’s especially effective in the treatment of two of the most common eye disorders: cataract and presbyopia. To put this in perspective, 68% of people aged 80 or older have either cataracts or have undergone cataract surgery. While virtually everyone will experience presbyopia as they get older. In other words, this is a big deal!
AkkoLens has previously secured millions of funding over multiple financing rounds to achieve important milestones, including compliance with European regulations and safety standards (CE registration). An additional €7 million has now been raised and allocated, enabling AkkoLens to conclude their Post Marketing Study (PMS) and to introduce the Lumina to the European market. Throughout this financing route, Impulse has provided support, serving as an impartial extension of AkkoLens management.
If you would like to know more about how the Lumina provides for a spectacle-free life, go to AkkoLens.com.